Mentioned On
Episode Mentions
Pharma and BioTech Daily · Jul 16, 2026
Veradermics' $2B Hair Loss Market Move with Oral Minoxidil | Pharma and Biotech Daily
“Positioned to explore tau-targeting approaches for neurodegenerative diseases following Biogen's validation”
Oral Minoxidil for Female Pattern Hair LossPatent Cliff Management in PharmaceuticalsAI-Driven Drug Discovery Partnerships
View Analysis
Biotech Hangout · May 8, 2026
Episode 182 - May 8, 2026
“Approved Hunter syndrome drug based on heparin sulfate biomarker; FDA rejected neurofilament data as primary evidence”
Biotech Secondary Capital Raises and Market SaturationFDA Regulatory Uncertainty and Commissioner McCary LeadershipM&A Activity in Biotech and Venture Capital Returns
View Analysis